Absorption of taurocholic acid by the ileum of normal and transgenic DeltaF508 cystic fibrosis mice.
Changes in intestinal transport in cystic fibrosis (CF) include both defective Cl(-) secretion and alterations in absorption. This study focused on the effects of CF on the active re-absorption of bile acids in the ileum of normal and transgenic CF mice. Taurocholic acid absorption was monitored as changes in short-circuit current (SCC) in intact and stripped ileal sheets from normal (Swiss) and transgenic CF (Cftr(tm2Cam)) mice with the DeltaF508 mutation. Taurocholic acid uptake was measured directly in everted ileal sacs and in brush-border membrane vesicles (BBMVs) using radiolabelled bile acid. Taurocholic acid caused a biphasic increase in SCC in both intact and stripped ileal sheets from Swiss mice. The initial phase of the response was associated with active bile acid absorption as it was inhibited by a low mucosal Na(+) concentration, but unaffected by Cl(-)-free conditions, serosal furosemide or mucosal diphenylamine-2-carboxylic acid (DPC). The first phase was concentration-dependent and was reduced in the presence of other actively transported bile acids. Intact ileal sheets from wild-type Cftr(tm2Cam) mice also exhibited a biphasic SCC response to taurocholic acid, but in CF tissues the initial phase was reduced and the second phase was absent. Taurocholic acid was actively taken up by everted ileal sacs from Swiss mice. This process was inhibited by a low mucosal Na(+) concentration or the presence of other actively transported bile acids. A similar taurocholic acid uptake was observed in ileal sacs from wild-type mice, but in those from CF mice transport of the bile acid was significantly reduced. However, taurocholic acid uptake was similar in BBMVs from wildtype and CF ilea. Active absorption of taurocholic acid occurs in mouse ileum and this process is reduced in transgenic mouse models of CF with the DeltaF508 mutation. However, this difference cannot be detected in an isolated preparation of brush-border membranes.
Hardcastle
J
J
Department of Biomedical Science, University of Sheffield, Sheffield, UK. j.hardcastle@sheffield.ac.uk
Harwood
M D
MD
Taylor
C J
CJ
D000818:Animals; D001692:Biological Transport; D001798:Blood Proteins / Q000235:genetics; D040501:Calgranulin A; D003550:Cystic Fibrosis / Q000378:metabolism*; D004553:Electric Conductivity; D007082:Ileum / Q000378:metabolism* / Q000503:physiopathology; D066298:In Vitro Techniques; D007408:Intestinal Absorption; D008297:Male; D051379:Mice; D008871:Microvilli / Q000378:metabolism; D009154:Mutation; D013656:Taurocholic Acid / Q000378:metabolism*
D001798:Blood Proteins; D040501:Calgranulin A; C026422:cystic fibrosis serum factor; D013656:Taurocholic Acid